Phase II study of combined external beam radiation therapy (EBRT), brachytherapy (PB), total androgen suppression (TAS), and adjuvant docetaxel (AD) in poor-risk, localized prostate cancer (PCa)
2004 ◽
Vol 22
(14_suppl)
◽
pp. 4764-4764
2004 ◽
Vol 22
(14_suppl)
◽
pp. 4764-4764
2000 ◽
Vol 48
(3)
◽
pp. 171
2003 ◽
Vol 2
(6)
◽
pp. 17
◽
2001 ◽
Vol 49
(3)
◽
pp. 679-684
◽